Eldepryl

Basic Eldepryl Information

• INN (International Nonproprietary Name): Selegiline (also known as Selegilina, Selegilinum, L‑Deprenalin).
• Brand Names Available In Australia: not specified.
• ATC Code: N04BD01 (Monoamine Oxidase B Inhibitors — anti‑parkinson drugs).
• Forms & Dosages: Tablet 5 mg, 10 mg; Capsule 5 mg; Orally Disintegrating Tablet (Zelapar) 1.25 mg; Transdermal Patch (Emsam) 6, 9, 12 mg/24hr.
• Manufacturers In Australia: not specified.
• Registration Status In Australia: not specified.
• OTC / Rx Classification: Prescription only (Rx) in most jurisdictions including US, UK and EU; verify local TGA listings for Australia.

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Are you in a group that needs extra caution?

• Pregnant or breastfeeding people: use not established; avoid unless essential and discussed with specialist.
• Elderly with polypharmacy: start at the lower end of dosing and monitor closely for orthostatic hypotension, hallucinations and drug interactions.
• Severe cardiovascular disease: uncontrolled hypertension or significant arrhythmias increase risk with selegiline.
• Uncontrolled hypertension: risk of hypertensive events with interacting substances or tyramine exposure.
• Psychiatric disorders (psychosis, mania): selegiline can worsen or precipitate symptoms.
• Significant liver impairment: reduced clearance may require lower doses and careful monitoring.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Worried about driving or safety‑critical work?

Selegiline can cause dizziness, orthostatic hypotension, insomnia or hallucinations.

Do not operate vehicles or heavy machinery until you know how it affects you.

Under Australian workplace laws, employers and workers must manage impairment risks where safety is critical.

• Before Driving — Checklist:
• Know your symptoms after the first doses and any dose increase.
• Stop driving if you feel drowsy, dizzy, lightheaded or have visual disturbances.
• Report new or troubling side effects to your prescriber or pharmacist immediately.
• Keep a written plan with your treating clinician if your job is safety critical.

Q&A — “Can I Drive After Taking It In Australia?”

Q: Can I drive?

A: Not until you know how it affects you.

If you feel drowsy, dizzy, or have visual disturbances, do not drive and inform your prescriber or pharmacist.

Report adverse effects to the TGA and your local pharmacist.

Usage Basics

INN, Brand Names Available In Australia

What is eldepryl and what names might you hear?

The INN is selegiline, also listed as Selegilina, Selegilinum and L‑Deprenalin in some sources.

Known brand names internationally include Eldepryl and Zelapar for oral forms, and Emsam for transdermal patches.

Local Australian brand availability should be checked via the TGA ARTG and wholesalers.

Legal Classification (TGA‑Approved, PBS‑Listed)

Selegiline is prescription‑only in most jurisdictions and classified as an MAO‑B inhibitor (ATC N04BD01).

TGA ARTG listings need to be checked for specific products and formulations registered in Australia.

PBS subsidy status varies by formulation and indication; some MAO‑B inhibitors are PBS‑listed for Parkinson’s with authority requirements.

Pharmacist role: confirm prescription, check interactions and counsel on storage and food cautions such as tyramine avoidance.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

How is eldepryl usually dosed for Parkinson’s?

Standard adult dosing for Parkinson’s is 5–10 mg daily, commonly 5 mg twice daily for tablets or capsules.

Zelapar ODT dosing is commonly 1.25–2.5 mg once daily.

Selegiline is used adjunctively with levodopa/carbidopa and clinicians may adjust levodopa dose when starting or stopping selegiline.

Adjustments For Comorbidities

Dosing guidance by group:

• Elderly: start at the lower end of the range and titrate carefully because sensitivity and interaction risk increase.
• Liver or renal impairment: use caution and monitor clinically; reduced clearance may necessitate dose changes.
• Pediatrics: use not established and not recommended.

• Dosing Tips & Monitoring Parameters:
• Review blood pressure and orthostatic symptoms after initiation.
• Monitor sleep patterns and neuropsychiatric symptoms (hallucinations, agitation).
• Perform medication reconciliation at each visit to avoid contraindicated combinations.

Q&A — “What If I Miss A Dose?”

Q: Missed dose?

A: Take as soon as remembered unless the next dose is due soon.

Do not double the next dose.

If unsure, contact your pharmacist or GP.

For overdose, seek emergency care — severe hypertension, agitation or seizures are possible.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

What foods and drinks should you watch with selegiline?

Selegiline is an MAO‑B inhibitor and can interact with tyramine‑rich foods causing hypertensive reactions in some cases.

Examples to moderate include matured cheeses, cured meats such as salami, some soy products and fermented foods.

Some craft beers and certain alcoholic beverages may contain higher tyramine levels; alcohol also worsens orthostatic effects and sleep disturbances.

Common Drug Conflicts

Which drugs must be avoided or monitored?

• Avoid combination with other MAO inhibitors and certain opioids such as meperidine.
• Strong serotonergic drugs (SSRIs, SNRIs, TCAs, tramadol) increase risk of serotonin syndrome and are contraindicated or require specialist oversight.
• Sympathomimetics such as pseudoephedrine and some nasal decongestants can elevate blood pressure; avoid or monitor closely.
• Triptans for migraine should be used with caution due to serotonergic effects.

Perform a full medication reconciliation at each dispensing to prevent dangerous interactions.

User Reports & Trends

Feedback From Australian Patients (ProductReview, Health Forums)

What are people saying about eldepryl in Australia?

Australian patient reports are similar to international feedback: many describe improved motor symptoms or reduced wearing‑off when used with levodopa.

Common negative experiences reported include insomnia, dizziness, dry mouth and vivid dreams.

Review sites and support forums show that formulation matters — ODT users report easier dosing for swallowing issues compared with tablets.

• Common Positive Themes: improved motor control, reduced off‑time, easier administration with ODT for dysphagia.
• Common Negative Themes: sleep disturbance, dizziness, dry mouth, variable effectiveness between patients.

Trends

There is growing interest in ODT formulations like Zelapar and in patches like Emsam overseas, although Emsam’s availability in Australia is not specified in the raw data.

Some patients look for cost savings through generics or online suppliers; emphasise regulatory checks and validated supply chains.

Anecdotal reports are not a substitute for clinical guidance and any adverse event should be reported to the TGA and discussed with a neurologist or pharmacist.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Where can you get eldepryl in Australia?

Selegiline is prescription‑only and availability depends on TGA registrations and local wholesalers.

Major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly dispense Parkinson’s medicines and can often source specific brands or generics.

In our online pharmacy, eldepryl is available without a prescription, with discreet delivery to Australia in 9-21 days.

Online Pharmacies And Telehealth E‑Prescriptions

Online and accredited e‑pharmacies may supply prescriptions but must require a valid prescription and have an Australian business presence for safe supply.

Telehealth appointments and e‑prescriptions are accepted at most pharmacies and are routinely used by GPs and neurologists to manage Parkinson’s.

• Safe Online Purchase Checklist:
• Verify TGA registration for the product.
• Ensure a valid prescription is required and a pharmacist contact is available.
• Confirm Australian business address and accreditation.

Rural patients may face stock delays; consider pharmacist‑assisted home delivery, early repeats or hospital pharmacy support for continuity of supply.

Mechanism & Pharmacology

Simplified Explanation

How does eldepryl work?

Selegiline is a selective irreversible MAO‑B inhibitor at typical Parkinson’s doses.

In plain terms, it reduces the breakdown of dopamine in the brain and thereby increases dopaminergic activity to help motor symptoms.

Different formulations alter absorption — tablets and capsules follow traditional oral absorption, ODTs disintegrate in the mouth and patches deliver drug transdermally.

Clinical Terms

Definition List:

• Mechanism: MAO‑B inhibition.
• Primary Effect: Increased dopamine availability in the brain.
• Result: Improved motor control and reduced wearing‑off when used with levodopa.

Clinical considerations include the potential to delay escalation of levodopa dose and the need to monitor for dose‑dependent neuropsychiatric effects, especially in the elderly and those on multiple medicines.

Indications & Off‑Label Uses

Approved Indications By TGA

What is eldepryl approved for?

Primary use is as an adjuvant in Parkinson’s disease to enhance dopaminergic therapy and reduce wearing‑off when combined with levodopa/carbidopa.

Check the TGA ARTG for specific registered indications and formulations currently approved in Australia.

Off‑Label Uses In Australian Clinical Practice

Transdermal selegiline (Emsam) is licensed in some countries for depression, but that indication and formulation’s registration in Australia is not specified in the raw data.

Other off‑label uses such as management of apathy or fatigue in neurodegenerative disease are reported internationally but lack strong evidence and require specialist oversight and informed consent.

Key Clinical Findings

Major Australian And International Studies 2022–2026

What do recent studies tell us?

• Selegiline continues to show modest symptomatic benefit as adjunctive therapy in Parkinson’s disease.
• Studies support a levodopa‑sparing effect in some patients, delaying dose escalation.
• Comparative data show rasagiline and safinamide as alternative MAO‑B inhibitors with different dosing and safety profiles.
• Safety signals emphasise insomnia, orthostatic hypotension and neuropsychiatric effects in elderly patients with polypharmacy.
• Drug interaction risks remain an important clinical consideration and limit simultaneous use with many serotonergic and opioid agents.

Gaps in the evidence include limited head‑to‑head Australian RCTs versus newer agents; clinicians rely on international RCTs, cohort studies and TGA guidance for local practice.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Pros And Cons Checklist

• Match patient priorities: dosing convenience, interaction profile, side‑effect burden, PBS subsidy and cost.
• Consider once‑daily agents for adherence and ODTs for swallowing issues.
• Review comorbidities and current medicines to minimise interaction risks.

Common Questions

FAQs From Australian Pharmacy Consultations

Patients often ask straightforward, practical questions.

• “Will it cure Parkinson’s?” — No; it manages symptoms and can delay levodopa escalation.
• “How long until benefit?” — Expect benefit over weeks; monitor motor fluctuations with your neurologist.
• “Can I mix with supplements/herbal meds?” — Disclose all OTC products; St John’s Wort and tryptophan may interact.
• “What are common side effects?” — Nausea, dry mouth, insomnia, dizziness, increased sweating, orthostatic hypotension and possible hallucinations in susceptible patients.

Pharmacists should use teach‑back, document counselling and advise patients to report adverse events to the TGA.

For occupational or legal questions about work safety, refer to the treating neurologist or occupational health service.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Confirm prescription and ARTG registration for the product before quoting price.
• Compare PBS subsidy vs private cost for concession card holders.
• For rural patients, plan repeats and deliveries ahead to avoid stock‑outs.

Registration & Regulation

TGA Approval

How to check regulatory status in Australia?

• Verify product registration on the TGA ARTG to confirm which selegiline products are registered.
• Check formulation, sponsor and ARTG number on the ARTG entry.
• Confirm approved indications and product SPC for local prescribing rules.

PBS Subsidy Details

PBS listings depend on indication, strength and pack size and may require authority prescriptions for Parkinson’s indications.

Consult the PBS Schedule and Health Professional Online Services for current subsidy rules and restrictions.

Report adverse events to the TGA and keep dispensing records for pharmacovigilance.

Pharmacists must ensure imported or online products meet Australian regulatory standards before dispensing.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store eldepryl at home?

Store in the original packaging at room temperature below 25°C, away from moisture and light.

Do not refrigerate or freeze tablets or capsules.

Avoid storing medicines in bathrooms or cars where humidity and heat can exceed recommended ranges.

• Household Storage Checklist:
• Keep below 25°C and away from direct sunlight.
• Retain original packaging and safety labels.
• Keep out of reach of children and pets.
• Dispose of expired medicines safely via pharmacy take‑back programs.

Cold‑Chain Handling For Pharmacies

Pharmacies should maintain ambient conditions and avoid extended heat exposure during transport.

Transdermal patches have specific SPC storage instructions that must be followed.

Provide written storage instructions with each dispense and consider blister packs for patients with handling or storage challenges.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

What should a pharmacist do at each dispense?

• Confirm indication and prescribing clinician.
• Review the full medication list including OTC and complementary medicines.
• Explain dosing schedule, missed‑dose instructions and storage.
• Highlight food and drink cautions (tyramine), common side effects and serious warning signs.
• Discuss driving and workplace safety and arrange follow‑up where needed.

Patient Advice From PBS And National Health Authorities

Refer patients to PBS leaflets, TGA consumer medicine information and Parkinson’s Australia resources for written guidance.

For complex cases coordinate with the treating neurologist and provide written instructions, counselling and adverse‑event reporting advice.

Emphasise adherence, safe storage, and urgent evaluation for signs of hypertensive crisis or serotonin syndrome.

Delivery Across Australia